Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
ATLANTA, Dec. 15, 2015 (GLOBE NEWSWIRE) -- The Genetics Policy Institute (GPI) and Regenerative Medicine Foundation (RMF) brought over a thousand scientists, clinicians, industry leaders, investors, government officials and patient advocates together for a three day conference designed to find cures and end human suffering at the 11th annual World Stem Cell Summit and the second annual RegMed Capital Conference, co-located at the Hyatt Regency in Atlanta, Georgia.
"For 11 years, the Genetics Policy Institute has gathered leaders from the stem cell and regenerative medicine community to share the latest scientific discoveries, pathways to deliver treatments to patients, and how to accelerate investment in this lifesaving research," said Bernard Siegel, Founder of the World Stem Cell Summit & RegMed Capital Conference and Executive Director of GPI.
Sessions at the 11th annual World Stem Cell Summit covered a range of disease areas and medical conditions including neurological disease, cardiovascular issues, spinal cord injury, cancer, HIV/AIDS, aging and more.
Speakers such as Dr. Robert M. Califf, President Obama's nominee to lead the Food and Drug Administration, discussed the role of regulations and pathways to connect research discoveries and patients in safe and ethical ways.
The impact of microgravity when studying stem cells on the International Space Station was a hot topic at the Summit as the Center for the Advancement of Science in Space (CASIS) led sessions on how space is a platform for innovation that can benefit all humankind.
Participants at the Summit also learned from the international community. With attendees from over 35 countries, sessions led by academic and industry leaders from outside the United States shared models for regulation and collaboration that can accelerate clinical application of regenerative medicine in Japan.
"With the convergence of innovative technologies, medical research is on the brink of breakthrough discoveries to tackle chronic disease," said Siegel. "The World Stem Cell Summit created a forum to accelerate the field by expanding knowledge and providing a platform to forge collaborations and facilitate progress."
|
|||||
The recently merged, Genetics Policy Institute/Regenerative Medicine Foundation, is a 501c3 nonprofit public interest organization, with the mission to promote public awareness, societal support and public policy initiatives for the fields of regenerative medicine, stem cell research and other advanced therapies, thereby accelerating their application in medicine for the purpose of delivering cures. We pursue this mission through production of our flagship annual World Stem Cell Summit & RegMed Capital Conference, publication of the annual World Stem Cell Report and newsletters, Stem Cell Action Awards, the Stem Cell Action Coalition, social media campaigns, special projects, speaking engagements, teaching initiatives and strategic collaborations. Learn more at http://www.genpol.org.
The 11th Annual World Stem Cell Summit & RegMed Capital Conference, the flagship meeting of the international stem cell community, was organized by the Genetics Policy Institute. The Summit (WSCS15) was organized by Genetics Policy Institute/Regenerative Medicine Foundation, The Georgia Center for Regenerative Engineering & Medicine (Emory University, Georgia Tech, University of Georgia), Mayo Clinic, Kyoto University Institute for Cell-Material Sciences (iCeMS), BioBridge Global, Wake Forest Institute for Regenerative Medicine and The New York Stem Cell Foundation. The goal of the Summit is to accelerate the discovery and development of lifesaving cures and therapies, bringing global stakeholders together to solve global challenges. The Summit forges collaborations to advance cell therapies, while creating a supportive environment of regulation, legislation, financing, reimbursement and patient advocacy.
Learn more at www.WorldStemCellSummit.com. Follow @WSCSummit on Twitter.
Media Contact: Judith Selzer, 561.909.8415
[email protected]
CONTACT: Judith Selzer
561.909.8415
[email protected]
